Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Janet Dancey"'
Autor:
Caroline Hamm MD, Dora Cavallo-Medved PhD, Devinder Moudgil PhD, Lee McGrath, John Huang, Yueyang Li, Tyler W. Stratton, Tyler Robinson, Krista Naccarato, Stephen Sundquist, Janet Dancey
Publikováno v:
Cancer Control, Vol 29 (2022)
Introduction Clinical trials, although academically accepted as the most effective treatment available for cancer patients, poor accrual to clinical trials remains a significant problem. A clinical trials navigator (CTN) program was piloted where pat
Externí odkaz:
https://doaj.org/article/d1ca806ad4ab4a18a405838f3e9f6da4
Autor:
Kamal S. Saini, Begoña de las Heras, Ruth Plummer, Victor Moreno, Marco Romano, Javier de Castro, Philippe Aftimos, Judy Fredriksson, Gouri Shankar Bhattacharyya, Martin Sebastian Olivo, Gaia Schiavon, Kevin Punie, Jesus Garcia-Foncillas, Ernesto Rogata, Richie Pfeiffer, Cecilia Orbegoso, Kenneth Morrison, Giuseppe Curigliano, Lynda Chin, Monika Lamba Saini, Øystein Rekdal, Steven Anderson, Javier Cortes, Manuela Leone, Janet Dancey, Chris Twelves, Ahmad Awada
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1357-1362 (2020)
Externí odkaz:
https://doaj.org/article/e753a4f9fda043498869674261249653
Autor:
Phillipe Joubert, Anil A. Joy, M. Mates, Ming-Sound Tsao, Glenwood D. Goss, Natasha B. Leighl, Keyue Ding, Normand Blais, Swati Kulkarni, Janet Dancey, Punam Rana, Scott A. Laurie, Martin R. Stockler, Penelope A. Bradbury, Sunil Yadav, Francisco E. Vera-Badillo, David M. Hwang, Craig Underhill, Christopher Lee, Andrea Hiltz, Brett G.M. Hughes
Publikováno v:
Journal of Thoracic Oncology. 17:434-445
First-line therapy for patients with metastatic NSCLC includes checkpoint inhibitor monotherapy, dual checkpoint inhibition, or combination with chemotherapy. We compared outcomes with combination chemoimmunotherapy versus dual checkpoint inhibition
Autor:
Janet Dancey, Holly Longstaff, Gerald Batist, Jim Pankovich, David K Lee, Kathy Brodeur-Robb, Bernhard J Eigl, Anna Sadura, Stephen Sundquist, Patrick S. Sullivan, Jaqueline Limoges, Kathryn Dyck
Publikováno v:
Current Oncology
Current Oncology, Vol 28, Iss 329, Pp 3857-3865 (2021)
Current Oncology, Vol 28, Iss 329, Pp 3857-3865 (2021)
Canada’s vast geography, and centralized delivery of cancer care and clinical trials create barriers for trial participation for patients in remote and rural settings. The development and implementation of a framework that enables safe and regulato
Autor:
Gregory R. Pond, Janet Dancey, Diana Kato, Saher Lalani, Stephen Sundquist, Rebecca Y. Xu, James Schoales
Publikováno v:
Current Oncology, Vol 28, Iss 248, Pp 2830-2839 (2021)
Current Oncology
Current Oncology
The Canadian Cancer Clinical Trials Network (3CTN) was established in 2014 to address the decline in academic cancer clinical trials (ACCT) activity. Funding was provided to cancer centres to conduct a Portfolio of ACCTs. Larger centres received core
Autor:
Valsamo K. Anagnostou, Cheryl Ho, Garth Nicholas, Rosalyn Anne Juergens, Adrian Sacher, Andrea Fung, Paul Wheatley-Price, Scott Laurie, Benjamin Levy, Julie Brahmer, Archana Balan, Noushin Niknafs, Egor Avrutin, Liting Zhu, Mark Sausen, Penelope Bradbury, Jill O'Donnell-Tormey, Pierre-Olivier Gaudreau, Keyue Ding, Janet Dancey
Publikováno v:
Cancer Research. 83:CT212-CT212
Introduction: Analyses of circulating tumor DNA (ctDNA) have shown promise in capturing tumor burden dynamics during immune checkpoint blockade (ICB), with the potential to allow patients with primary resistance to be rapidly identified and redirecte
Autor:
Monica M. Bertagnolli, Susan M. Blaney, Robert S. Mannel, Walter J. Curran, Janet Dancey, Charles D. Blanke, Peter J. O'Dwyer, Norman Wolmark, Mitchell D. Schnall
Publikováno v:
JNCI: Journal of the National Cancer Institute. 111:11-18
The Coalition of Cancer Cooperative Groups is an organization representing the interests of patients and researchers who conduct research through the National Cancer Institute-supported National Clinical Trials Network (NCTN). The NCTN provides a cru
Publikováno v:
Handbook of Therapeutic Biomarkers in Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f78b712fd8933ac43cf49104b03c1b16
https://doi.org/10.1201/9781003159469-16
https://doi.org/10.1201/9781003159469-16
Autor:
Janet Dancey, Jose Gerard Monzon
Publikováno v:
Handbook of Therapeutic Biomarkers in Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::589a730af2bb041670cb23b3bfa18a66
https://doi.org/10.1201/9781003159469-7
https://doi.org/10.1201/9781003159469-7